Atlas Discovery is a startup based in San Francisco, founded in 2026, with a team of three. The company specializes in leveraging artificial intelligence to predict how humans will respond to drugs during clinical trials. By analyzing complex biological and clinical data, the platform aims to improve the accuracy of trial outcomes and reduce development risks.
The company operates within the biotechnology sector, focusing on AI-driven drug discovery solutions. It has been recognized as a verified startup on Nova Startup, a premium global directory for emerging technology ventures. Atlas Discovery is part of the Summer 2026 cohort, highlighting its early-stage innovation in applying machine learning to pharmaceutical research.